Does SOTORASIB Cause Contraindicated product administered? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Contraindicated product administered have been filed in association with SOTORASIB (LUMAKRAS). This represents 0.2% of all adverse event reports for SOTORASIB.
5
Reports of Contraindicated product administered with SOTORASIB
0.2%
of all SOTORASIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Contraindicated product administered From SOTORASIB?
Of the 5 reports.
Is Contraindicated product administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOTORASIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does SOTORASIB Cause?
Non-small cell lung cancer (483)
Death (319)
Disease progression (314)
Diarrhoea (284)
Off label use (193)
Nausea (98)
Non-small cell lung cancer metastatic (93)
Hepatotoxicity (91)
Fatigue (87)
Hepatic function abnormal (80)
What Other Drugs Cause Contraindicated product administered?
ABATACEPT (13,559)
METHOTREXATE (13,121)
ETANERCEPT (12,062)
TOCILIZUMAB (11,547)
ADALIMUMAB (11,270)
LEFLUNOMIDE (11,206)
HYDROXYCHLOROQUINE (10,557)
RITUXIMAB (10,479)
INFLIXIMAB (9,618)
SULFASALAZINE (8,698)
Which SOTORASIB Alternatives Have Lower Contraindicated product administered Risk?
SOTORASIB vs SOTROVIMAB
SOTORASIB vs SOVALDI
SOTORASIB vs SOYBEAN OIL
SOTORASIB vs SPARSENTAN
SOTORASIB vs SPARTALIZUMAB